John Glenn - 03 Mar 2026 Form 4 Insider Report for IRADIMED CORP (IRMD)

Role
CHIEF FINANCIAL OFFICER
Signature
/s/ John Glenn
Issuer symbol
IRMD
Transactions as of
03 Mar 2026
Net transactions value
$0
Form type
4
Filing time
05 Mar 2026, 14:42:24 UTC
Previous filing
12 Dec 2025
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
GLENN JOHN CHIEF FINANCIAL OFFICER C/O IRADIMED CORPORATION, 12705 INGENUITY DRIVE, ORLANDO /s/ John Glenn 05 Mar 2026 0001253497

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction IRMD Restricted Stock Units Award +8,907 $0.000000* 8,907 03 Mar 2026 Common Stock 8,907 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Restricted stock units ("RSUs") convert into common stock on a one-for-one basis.
F2 The reporting person received RSUs under Iradimed Corporation's 2023 Equity Incentive Plan. The RSUs vest in three equal annual installments beginning on December 7, 2026. Upon vesting, the reporting person will receive a number of shares of common stock equal to the number of RSUs that have vested.